A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Read more about A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas. Read more about The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas.
Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Read more about Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Read more about Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma.
ERCC1 and ERCC2 polymorphisms and adult glioma. Read more about ERCC1 and ERCC2 polymorphisms and adult glioma.
GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials. Read more about GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials.
High failure rate in spinal ependymomas with long-term follow-up. Read more about High failure rate in spinal ependymomas with long-term follow-up.
Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature. Read more about Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature.
Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts. Read more about Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.
Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Read more about Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis.
